BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 22899245)

  • 1. The candidate tumor suppressor gene Ecrg4 as a wound terminating factor in cutaneous injury.
    Shaterian A; Kao S; Chen L; DiPietro LA; Coimbra R; Eliceiri BP; Baird A
    Arch Dermatol Res; 2013 Mar; 305(2):141-9. PubMed ID: 22899245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary preconditioning, injury, and inflammation modulate expression of the candidate tumor suppressor gene ECRG4 in lung.
    Kao S; Shaterian A; Cauvi DM; Dang X; Chun HB; De Maio A; Costantini TW; Coimbra R; Eliceiri BP; Baird A
    Exp Lung Res; 2015 Apr; 41(3):162-72. PubMed ID: 25513848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The candidate tumor suppressor gene ECRG4 inhibits cancer cells migration and invasion in esophageal carcinoma.
    Li L; Zhang C; Li X; Lu S; Zhou Y
    J Exp Clin Cancer Res; 2010 Oct; 29(1):133. PubMed ID: 20937111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell surface localization and release of the candidate tumor suppressor Ecrg4 from polymorphonuclear cells and monocytes activate macrophages.
    Baird A; Coimbra R; Dang X; Lopez N; Lee J; Krzyzaniak M; Winfield R; Potenza B; Eliceiri BP
    J Leukoc Biol; 2012 May; 91(5):773-81. PubMed ID: 22396620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Esophageal cancer related gene-4 is a choroid plexus-derived injury response gene: evidence for a biphasic response in early and late brain injury.
    Podvin S; Gonzalez AM; Miller MC; Dang X; Botfield H; Donahue JE; Kurabi A; Boissaud-Cooke M; Rossi R; Leadbeater WE; Johanson CE; Coimbra R; Stopa EG; Eliceiri BP; Baird A
    PLoS One; 2011; 6(9):e24609. PubMed ID: 21935431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ecrg4 expression and its product augurin in the choroid plexus: impact on fetal brain development, cerebrospinal fluid homeostasis and neuroprogenitor cell response to CNS injury.
    Gonzalez AM; Podvin S; Lin SY; Miller MC; Botfield H; Leadbeater WE; Roberton A; Dang X; Knowling SE; Cardenas-Galindo E; Donahue JE; Stopa EG; Johanson CE; Coimbra R; Eliceiri BP; Baird A
    Fluids Barriers CNS; 2011 Jan; 8(1):6. PubMed ID: 21349154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of esophageal cancer related gene 4 (ECRG4), a novel tumor suppressor gene, in esophageal cancer and its inhibitory effect on the tumor growth in vitro and in vivo.
    Li LW; Yu XY; Yang Y; Zhang CP; Guo LP; Lu SH
    Int J Cancer; 2009 Oct; 125(7):1505-13. PubMed ID: 19521989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of candidate tumor suppressor ECRG4 inhibits glioma proliferation and invasion.
    Li W; Liu X; Zhang B; Qi D; Zhang L; Jin Y; Yang H
    J Exp Clin Cancer Res; 2010 Jul; 29(1):89. PubMed ID: 20598162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ECRG4 as a novel tumor suppressor gene inhibits colorectal cancer cell growth in vitro and in vivo.
    Cai Z; Liang P; Xuan J; Wan J; Guo H
    Tumour Biol; 2016 Jul; 37(7):9111-20. PubMed ID: 26762416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ECRG4 regulates neutrophil recruitment and CD44 expression during the inflammatory response to injury.
    Dorschner RA; Lee J; Cohen O; Costantini T; Baird A; Eliceiri BP
    Sci Adv; 2020 Mar; 6(11):eaay0518. PubMed ID: 32195341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ECRG4 is a candidate tumor suppressor gene frequently hypermethylated in colorectal carcinoma and glioma.
    Götze S; Feldhaus V; Traska T; Wolter M; Reifenberger G; Tannapfel A; Kuhnen C; Martin D; Müller O; Sievers S
    BMC Cancer; 2009 Dec; 9():447. PubMed ID: 20017917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Tumor-suppressing function of human esophageal cancer related gene 4 in esophageal squamous cell carcinoma].
    Li LW; Yang Y; Li XY; Guo LP; Zhou Y; Lu SX
    Zhonghua Yi Xue Za Zhi; 2010 Oct; 90(38):2713-7. PubMed ID: 21162904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum exosomes contain ECRG4 mRNA that suppresses tumor growth via inhibition of genes involved in inflammation, cell proliferation, and angiogenesis.
    Mao L; Li X; Gong S; Yuan H; Jiang Y; Huang W; Sun X; Dang X
    Cancer Gene Ther; 2018 Oct; 25(9-10):248-259. PubMed ID: 29983418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of ECRG4, a candidate tumor suppressor gene, in human breast cancer.
    Sabatier R; Finetti P; Adelaide J; Guille A; Borg JP; Chaffanet M; Lane L; Birnbaum D; Bertucci F
    PLoS One; 2011; 6(11):e27656. PubMed ID: 22110708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ECRG4 acts as a tumor suppressor gene frequently hypermethylated in human breast cancer.
    Tang GY; Tang GJ; Yin L; Chao C; Zhou R; Ren GP; Chen JY; Zhang W
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 30918105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-specific processing and release of the hormone-like precursor and candidate tumor suppressor gene product, Ecrg4.
    Dang X; Podvin S; Coimbra R; Eliceiri B; Baird A
    Cell Tissue Res; 2012 Jun; 348(3):505-14. PubMed ID: 22526622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel tumor suppressor gene ECRG4 interacts directly with TMPRSS11A (ECRG1) to inhibit cancer cell growth in esophageal carcinoma.
    Li LW; Li YY; Li XY; Zhang CP; Zhou Y; Lu SH
    BMC Cancer; 2011 Feb; 11():52. PubMed ID: 21288367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin (IL)-19 promoted skin wound healing by increasing fibroblast keratinocyte growth factor expression.
    Sun DP; Yeh CH; So E; Wang LY; Wei TS; Chang MS; Hsing CH
    Cytokine; 2013 Jun; 62(3):360-8. PubMed ID: 23582717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Esophageal cancer-related gene 4 at the interface of injury, inflammation, infection, and malignancy.
    Baird A; Lee J; Podvin S; Kurabi A; Dang X; Coimbra R; Costantini T; Bansal V; Eliceiri BP
    Gastrointest Cancer; 2014; 2014(4):131-142. PubMed ID: 25580077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ECRG4 acts as a tumor suppressor and as a determinant of chemotherapy resistance in human nasopharyngeal carcinoma.
    You Y; Yang W; Qin X; Wang F; Li H; Lin C; Li W; Gu C; Zhang Y; Ran Y
    Cell Oncol (Dordr); 2015 Jun; 38(3):205-14. PubMed ID: 25707757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.